Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).
Ziefle S, Egberts F, Heinze S, Volkenandt M, Schmid-Wendtner M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Heinz A, Hauschild A, Schaefer M. Ziefle S, et al. Among authors: spieth k. J Immunother. 2011 May;34(4):403-8. doi: 10.1097/CJI.0b013e31821b7a4b. J Immunother. 2011. PMID: 21499123 Clinical Trial.
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.
Hauschild A, Weichenthal M, Rass K, Linse R, Berking C, Böttjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Stein A, Näher H, Schadendorf D, Mohr P, Kaatz M, Tronnier M, Hein R, Schuler G, Egberts F, Garbe C. Hauschild A, et al. Among authors: spieth k. J Clin Oncol. 2010 Feb 10;28(5):841-6. doi: 10.1200/JCO.2009.23.1704. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048184 Clinical Trial.
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
Heinze S, Egberts F, Rötzer S, Volkenandt M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Hinzpeter A, Hauschild A, Schaefer M. Heinze S, et al. Among authors: spieth k. J Immunother. 2010 Jan;33(1):106-14. doi: 10.1097/CJI.0b013e3181b8bdb9. J Immunother. 2010. PMID: 19952950 Clinical Trial.
[Working Group of Dermatologic Oncology (ADO)].
Spieth K. Spieth K. J Dtsch Dermatol Ges. 2009 Jan;7(1):89. doi: 10.1111/j.1610-0387.2008.06995.x. J Dtsch Dermatol Ges. 2009. PMID: 19138302 German. No abstract available.
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Spieth K, Kaufmann R, Dummer R, Garbe C, Becker JC, Hauschild A, Tilgen W, Ugurel S, Beyeler M, Bröcker EB, Kaehler KC, Pföhler C, Gille J, Leiter U, Schadendorf D. Spieth K, et al. Ann Oncol. 2008 Apr;19(4):801-6. doi: 10.1093/annonc/mdm565. Epub 2008 Jan 4. Ann Oncol. 2008. PMID: 18178958 Free article. Clinical Trial.
Febrile ulceronecrotic lymphomatoid papulosis.
Henke U, Spieth K, Ziper F, Wolter M, Oeschger S, Böer A, Kaufmann R. Henke U, et al. Among authors: spieth k. J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1260-1. doi: 10.1111/j.1468-3083.2007.02150.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17894721 No abstract available.
[Postoperative pyoderma gangrenosum of Cullen].
Valesky EM, Spieth K, Beier C, Wolter M, Kaufmann R. Valesky EM, et al. Among authors: spieth k. Unfallchirurg. 2007 Nov;110(11):973-6. doi: 10.1007/s00113-007-1283-x. Unfallchirurg. 2007. PMID: 17786400 German.
26 results